期刊文献+

丹参注射液治疗肾病的临床分析 被引量:2

Clinical analysis of renal disease therapy with Danshen injection
下载PDF
导出
摘要 目的探讨丹参注射液治疗肾病的有效治疗方法。方法回顾性研究笔者所在医院治疗的70例肾病患者的临床资料,按照治疗方法的不同分为治疗组和对照组各35例。两组先行常规治疗,治疗组在常规治疗的基础上,加用丹参注射液,通过临床疗效及血液流变学变化进行比较。结果两组比较结果显示,治疗组患者临床症状和血液流变学指标优于对照组。两组患者数据组间比较,差异有统计学意义(P<0.05)。结论应用丹参注射液治疗肾病,具有明显的临床效果,有临床推广的价值。 Objective To explore the effective curative method of renal disease therapy with Danshen injection.Methods A retrospectively clinical data of 70 cases with renal disease in the author's hospital was analysed,and they were divided into a treatment group(35 cases) and control group(35 cases) according to the difference of treatment.All cases were treated with conventional therapy,on this basis,cases of treatment group additionally adopted Danshen injection.And the clinical effect and changes of blood rheology were compared.Results Two groups of comparison results showed that clinical symptoms and index of blood rheology of treatment group better than control group,the differences were statistically significant(P 0.05).Conclusion There is visible clinical effect of renal disease therapy with Danshen injection,and worth popularizing.
作者 朱全军
出处 《中国医药科学》 2012年第22期72-73,共2页 China Medicine And Pharmacy
关键词 肾病 丹参注射液 疗效 血液流变学 Renal disease Danshen injection Effective Blood rheology
  • 相关文献

参考文献7

二级参考文献43

共引文献57

同被引文献32

  • 1袁军,鲁艳芳,陈陶后,曾祥法.丹参对血管紧张素Ⅱ诱导的肾小球系膜细胞表达TGF-β_1,ROS和PAI-1的影响[J].中国中药杂志,2007,32(22):2400-2404. 被引量:38
  • 2Kang DG, Yun YG, Ryoo JH, et al. Anti - hypertensive effect of water extract of danshen on renovascular hypertension through inhi- bition of the renin angiotensin system [J]. Am J Chin Med,2002, 30(1) :87 -93.
  • 3Yuan J, Wang X, Chen T, et al. Salvia mihiorrhiza depresses plas- minogen activator inhibitor - 1 production through inhibition of an- giotensin II [ J]. Am J Chin Med,2008,36(5 ) :1005 -1015.
  • 4Matsui F, Meldrum KK. The role of the Janus kinase family/signal transducer and activator of transcription signaling pathway in fibrot- ic renal disease [ J ]. J Surg Res ,2012,178 (1) :339 -345.
  • 5Amiri F, Shaw S,Wang X,et al. Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose [ J ]. Kidney Int,2002,61 ( 5 ) : 1605 - 1616.
  • 6Chuang PY, He JC. JAK/STAT signaling in renal diseases [J]. Kidney Int,2010,78 ( 3 ) :231 - 234.
  • 7Marrere MB, Schieffer B, Paxton WG, et al. Direct stimulation of Jak/STAT pathway by the angiotensiu II AT1 receptor [ J ]. Na- ture, 1995,375 (6528) :247 - 250.
  • 8Amiri F, Venema V J, Wang X, et al. Hyperglycemia enhances an- giotensin II - induced janus - activated kinase/STAT signaling in vascular smooth muscle cells [ J ]. J Biol Chem, 1999,274 ( 45 ) :32382 - 32386.
  • 9Venema RC, Venema VJ, Eaton DC, et al. Angiotensin II - induced tyrosine phosphorylation of signal transducers and activators of transcription 1 is regulated by Janus - activated kinase 2 and Fyn kinases and mitogen- activated protein kinase phosphatase 1 [J]. J Biol Chem, 1998,273 (46) :30795 - 30800.
  • 10Wang X,Shaw S,Amiri F,et al. Inhibition of the Jak/STAT signa- ling pathway prevents the high glucose - induced increase in TGF -beta and fibronectin synthesis in mesangial cells [ J ]. Diabetes, 2002,51 ( 12 ) :3505 - 3509.

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部